A Single Center, Randomized, Double-blind, Single-dose, Four Period, Crossover Study to Investigate Pharmacodynamics and Pharmacokinetics of RO4917838 Alone or With Concomitant Administration of Alcohol in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 16 May 2017
At a glance
- Drugs Bitopertin (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 15 Aug 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 25 Jul 2012 Planned End Date changed from 1 Aug 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 25 Jul 2012 Actual initiation date (Feb 2012) added as reported by ClinicalTrials.gov.